CVS Caremark Praises FTC Report Supporting Pro-Consumer Approach to Biogeneric Competition
U.S. Newswire, June, 2009
To: RETAILING EDITORS
Contact: Christine Cramer, 1-401-770-3317, ckcramer@cvs.com, or Steve Campanini, 1-401-770-5005, slcampanini@cvs.com, both Corporate Communications of CVS Caremark
WOONSOCKET, R.I., June 11 /PRNewswire/ -- CVS Caremark (NYSE: CVS) today applauded a Federal Trade Commission (FTC) report issued this week for its pro-consumer leadership in the debate about how to create a legislative pathway for the approval of biogenerics that reasonably balances innovation with competition.
(Logo: http://www.newscom.com/cgi-bin/prnh/20090226/NE75914LOGO)
Dave Golding, R.Ph., Executive Vice President for Specialty Pharmacy services at CVS Caremark, participated in an FTC Roundtable event last fall on the issue. In addition, the company has provided...
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- Design a commission plan that drives sales - Sales Commissions
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- LIFO vs. FIFO: a return to the basics
